To the Editor: We report significant sinus bradycardia in a patient presenting with an acute coronary syndrome shortly after beginning bupropion therapy to assist with smoking cessation.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- Department of Cardiology, Royal Melbourne Hospital, Melbourne, VIC.
Correspondence: andrew.ajani@mh.org.au
- 1. eMIMS. Prescribing information: Zyban. Sydney: CMP Medica Australia, 2006 (updated 25 May 2006). Subscription only. http://mims.hcn.net.au (accessed Dec 2007).
- 2. Kotlyar M, Brauer LH, Tracy TS, et al. Inhibition of CYP2D6 activity by bupropion. J Clin Psychopharmacol 2005; 25: 226-229.
- 3. McCollum DL, Greene JL, McGuire DK. Severe sinus bradycardia after initiation of bupropion therapy: a probable drug–drug interaction with metoprolol. Cardiovasc Drugs Ther 2004; 18: 329-330.
- 4. Baumann P. Pharmacokinetic–pharmacodynamic relationship of the selective serotonin reuptake inhibitors. Clin Pharmacokinet 1996; 31: 444-469.
- 5. Konig F, Hafele M, Hauger B, et al. Bradycardia after beginning therapy with metoprolol and paroxetine. Psychiatr Prax 1996; 23: 244-245.
- 6. Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 1997; 17: 208-221.
Online responses are no longer available. Please refer to our instructions for authors page for more information.